How Do We Improve Patient Compliance and Adherence to Long-Term Statin Therapy?

被引:146
作者
Maningat, Patricia [1 ]
Gordon, Bruce R. [2 ]
Breslow, Jan L. [1 ]
机构
[1] Rockefeller Univ, New York, NY 10065 USA
[2] Rogosin Inst, New York, NY 10021 USA
关键词
Statin; Adherence; Compliance; Patient-physician communication; Adverse events; Lipid-lowering; CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; LIPID-LOWERING MEDICATION; CARDIOVASCULAR RISK; PILL COMBINATION; LDL CHOLESTEROL; HEALTH; PREVENTION; PHYSICIAN; INTERVENTION;
D O I
10.1007/s11883-012-0291-7
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Statins are highly effective drugs prescribed to millions of people to lower LDL-cholesterol and decrease cardiovascular risk. The benefits of statin therapy seen in randomized clinical trials will only be replicated in real-life if patients adhere to the prescribed treatment regimen. But, about half of patients discontinue statin therapy within the first year, and adherence decreases with time. Patient, physician and healthcare system-related factors play a role in this problem. Recent studies have focused more on the patients' perspectives on non-adherence. Adverse events are cited as the most common cause of statin discontinuation; thus, the healthcare provider must be willing to ally and dialogue with patients to address concerns and assess the risks and benefits of continued statin therapy.
引用
收藏
页数:8
相关论文
共 76 条
[1]   Communicating With Physicians About Medical Decisions: A Reluctance to Disagree [J].
Adams, Jared R. ;
Elwyn, Glyn ;
Legare, France ;
Frosch, Dominick L. .
ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (15) :1184-1186
[2]  
AIM-HIGH Investigators, 2011, AM HEART J, V161
[3]  
[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc35-S011, 10.2337/dc12-s004]
[4]  
[Anonymous], NEW RESTR CONTR DOS
[5]  
[Anonymous], 2012, FDA DRUG SAFETY COMM
[6]  
Aubert RE, 2010, AM J MANAG CARE, V16, P459
[7]   Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].
Baigent, C. ;
Blackwell, L. ;
Emberson, J. ;
Holland, L. E. ;
Reith, C. ;
Bhala, N. ;
Peto, R. ;
Barnes, E. H. ;
Keech, A. ;
Simes, J. ;
Collins, R. .
LANCET, 2010, 376 (9753) :1670-1681
[8]   Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence [J].
Balu, Sanjeev ;
Simko, Robert J. ;
Quimbo, Ralph M. ;
Cziraky, Mark J. .
CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (11) :2765-2775
[9]   Monitoring adherence to drug treatment by using change in cholesterol concentration: secondary analysis of trial data [J].
Bell, Katy J. L. ;
Kirby, Adrienne ;
Hayen, Andrew ;
Irwig, Les ;
Glasziou, Paul .
BMJ-BRITISH MEDICAL JOURNAL, 2011, 342 :269
[10]   Long-term persistence in use of statin therapy in elderly patients [J].
Benner, JS ;
Glynn, RJ ;
Mogun, H ;
Neumann, PJ ;
Weinstein, MC ;
Avorn, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (04) :455-461